Investor News View all

Doseology Announces Option Grant
Doseology Announces $1.2M Private Placement to Advance Commercialization
Doseology Appoints Chris Jackson, Founder of Qtrade, as Chief Executive Officer and a Director
Doseology Invests into the Multi-Billion-Dollar U.S. Modern Oral Stimulant Market
Executive Realignment at Doseology to Drive Future Expansion
Doseology Appoints New CFO and Expands Distribution Reach
Doseology Grows Canadian Retail Sales with Loblaw Companies
Doseology Announces CEO Transition
Doseology Welcomes New CFO